PANACEA BIOTECH Fact Sheet, PANACEA BIOTECH Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH Fact Sheet   (PANB)


Watch Now: One Stock Crorepati Replay is Available Now


Here is the latest financial fact sheet of PANACEA BIOTECH. For more details, see the PANACEA BIOTECH quarterly results and PANACEA BIOTECH share price and chart. For a sector overview, read our pharmaceuticals sector report.

PANACEA BIOTECH Price History

Price Rs 128.4
Mkt Cap Rs m 7,862
Vol '000 2.3
P/E X 0.7
P/CF X -7.7
EPS (TTM) Rs 176.0
1 Day % 0.0
No. of shares m 61.25
1 Week % -0.5
1 Month % -10.9
1 Year % -65.2
52 week H/L Rs 411.0/125.2
As on Jul 1, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PANACEA BIOTECH Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
PANACEA BIOTECH EQUITY SHARE DATA
High Rs178364354215265 
Low Rs8612913890110 
Sales per share (Unadj.) Rs86.596.274.688.8102.0 
Earnings per share (Unadj.) Rs-9.2-12.46.1-31.8-24.1 
Diluted earnings per shareRs-9.2-12.46.1-31.8-24.1 
Cash flow per share (Unadj.) Rs1.9-2.915.1-24.6-16.6 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs58.150.457.227.2-37.3 
Adj. book value per shareRs58.150.457.227.2-37.3 
Shares outstanding (eoy) m61.2561.2561.2561.2561.25 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.52.63.31.71.8 
Avg P/E ratio x-14.3-19.840.1-4.8-7.8 
P/CF ratio (eoy) x70.4-85.516.3-6.2-11.3 
Price / Book Value ratio x2.34.94.35.6-5.0 
Dividend payout %00000 
Avg Mkt Cap Rs m8,07915,10115,0629,32511,498 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,4811,5161,4711,4441,563 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
PANACEA BIOTECH INCOME DATA
Net Sales Rs m5,3015,8944,5675,4416,248 
Other income Rs m4668251304106 
Total revenues Rs m5,7675,9774,6185,7446,354 
Gross profit Rs m5488452,009101757 
Depreciation Rs m680585550441461 
Interest Rs m1,0091,0061,0481,7401,853 
Profit before tax Rs m-675-663461-1,777-1,451 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-110998617026 
Profit after tax Rs m-565-762375-1,946-1,477 
Gross profit margin %10.314.344.01.912.1 
Effective tax rate %16.3-14.918.6-9.5-1.8 
Net profit margin %-10.7-12.98.2-35.8-23.6 
PANACEA BIOTECH BALANCE SHEET DATA
Current assets Rs m7,0325,6485,0796,8335,110 
Current liabilities Rs m6,8916,9559,3836,2215,959 
Net working cap to sales %2.7-22.2-94.211.2-13.6 
Current ratio x1.00.80.51.10.9 
Inventory Days Days272516130114 
Debtors Days Days9884714649 
Net fixed assets Rs m10,70910,2758,4788,7538,379 
Share capital Rs m6161616161 
"Free" reserves Rs m3,4963,0263,4431,607-2,348 
Net worth Rs m3,5573,0873,5041,668-2,287 
Long term debt Rs m7,1415,7074616,1317,351 
Total assets Rs m17,74115,92413,55715,58513,489 
Interest coverage x0.30.31.400.2 
Debt to equity ratio x2.01.80.13.7-3.2 
Sales to assets ratio x0.30.40.30.30.5 
Return on assets %2.51.510.5-1.32.8 
Return on equity %-15.9-24.710.7-116.764.6 
Return on capital %3.13.938.1-0.57.9 
Exports to sales %34.624.220.926.834.8 
Imports to sales %11.715.56.014.89.0 
Exports (fob) Rs m1,8321,4249541,4602,176 
Imports (cif) Rs m621912273807560 
Fx inflow Rs m1,9981,6001,2031,5732,270 
Fx outflow Rs m8981,131741878657 
Net fx Rs m1,1014694626951,613 
PANACEA BIOTECH CASH FLOW
From Operations Rs m 1,307 1,180 1,048 -305 1,068 
From Investments Rs m -258 553 -53 -348 -477 
From Financial Activity Rs m -1,070 -1,643 -1,011 907 -471 
Net Cashflow Rs m -21 90 -20 258 119 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 73.6%
Institution 0.0%
Non-Institution 26.4%
Total 100.0%
Free Float 26.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Ambala - Chandigarh Highway, Lalru - 140501
E-mail companysec@panaceabiotec.com Web www.panaceabiotec.com
Tel 01762- 505900 Fax 01762- 505909 / 505906
Sector PHARMACEUTICALS Group Soshil Kumar Jain
Tr Agent Skyline Financial Services Pvt Ltd, D-153/A 1st Floor, Okhla Industrial Area, Phase - I
Auditor S. R. Batliboi & Co.
CHM: Soshil Kumar Jain COMP SEC: Vinod Goel YEAR OF INC: 1984 BSE CODE: 531349 FV (Rs): 1 DIV YIELD (%): -

Read: PANACEA BIOTECH 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare PANACEA BIOTECH With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

Wait! Don't Buy the Smallcap 'Dip' Just Yet (Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

5 Consistent Compounding Stocks Available at Discount. Time to Buy? (Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks (Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - GRANULES INDIA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS